1BUCK K D, MCLEOD H J, GUMLEY A, et al. Anhedonia in prolonged schizophrenia spectrum patients with relatively lower vs. higher levels of depression disorders: associations with deficits in social cognition and metaeognition [ J]. Conscious Cogn, 2014, 29 : 68 - 75.
2GOFF D C, MCEVOY J P, CITROME L, et al. High - dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study [ J ]. J Clin Psycho- pharmacol, 2013, 33(4): 485-490.
3CHANDRAPPA P, HO L. Case reports of patients with treatment - resistant schizophrenia and related psychotic disorders intolerant to elozapine responding to high doses of quetiapine[ J]. Ther Adv Psy- chopharmaeol, 2012, 2(5) : 207 -209.
4AU R W, MAN D, SHUM D, et al. Assessment of prospective memory in schizophrenia using the Chinese version of the Cam- bridge Prospective Memory Test: a controlled study [ J 1. Asia Pac Psychiatry, 2014, 6 (1): 54- 61.
5PERROT S, RUSSELL ! L. More ubiquitous effects from non - pharmacologic than from pharmacologic treatments for fibromyalgia syndrome : a meta - analysis examining six core symptoms[J]. Eur J Pain, 2014, 18(8) :1067 -1080.
